To provide further validation for TRIM26 expression in malignant cells, we used an independent, published scRNA-seq dataset of 28 GBM tumors, which demonstrated that TRIM26 is more highly expressed in GBM tumor cells compared to nonmalignant cells (Fig. 1J). The gene discussed is TRIM26; the disease is neoplasm.